Literature DB >> 24433619

Galectin-3 expression in cardiac remodeling after myocardial infarction.

J Sanchez-Mas1, A Lax2, M C Asensio-Lopez2, M J Fernandez-Del Palacio3, L Caballero2, I P Garrido2, F Pastor2, J L Januzzi4, D A Pascual-Figal2.   

Abstract

Entities:  

Keywords:  Cardiac remodeling; Fibrosis; Galectin-3; Heart failure; Myocardial infarction

Mesh：

Substances：

Year:  2014        PMID： 24433619     DOI： 10.1016/j.ijcard.2013.12.129

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  16 in total

1.  Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling.

Authors:  Umesh C Sharma; Wassim Mosleh; Milind R Chaudhari; Rujuta Katkar; Brian Weil; Chris Evelo; Thomas R Cimato; Saraswati Pokharel; W Matthijs Blankesteijn; Gen Suzuki
Journal:  Heart Lung Circ       Date:  2016-12-19       Impact factor: 2.975

Review 2.  Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead.

Authors:  Hui Tao; Jing-Jing Yang; Wei Hu; Kai-Hu Shi; Zi-Yu Deng; Jun Li
Journal:  Pflugers Arch       Date:  2016-01-20       Impact factor: 3.657

3.  Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study.

Authors:  Ana Djordjevic; Maja Zivkovic; Aleksandra Stankovic; Ivan Zivotic; Igor Koncar; Lazar Davidovic; Dragan Alavantic; Tamara Djuric
Journal:  J Clin Lab Anal       Date:  2016-05-21       Impact factor: 2.352

4.  Left ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective study.

Authors:  Ana Djordjevic; Milica Dekleva; Maja Zivkovic; Aleksandra Stankovic; Natasa Markovic Nikolic; Dragan Alavantic; Tamara Djuric
Journal:  Mol Biol Rep       Date:  2018-09-18       Impact factor: 2.316

Review 5.  Critical effects of long non-coding RNA on fibrosis diseases.

Authors:  Yue Zhang; Gang Luo; Yi Zhang; Mengjie Zhang; Jian Zhou; Weiwu Gao; Xiuyun Xuan; Xia Yang; Di Yang; Zhiqiang Tian; Bing Ni; Jun Tang
Journal:  Exp Mol Med       Date:  2018-01-19       Impact factor: 8.718

6.  Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction.

Authors:  Olivera M Andrejic; Rada M Vucic; Milan Pavlovic; Lana McClements; Dragana Stokanovic; Tatjana Jevtovic-Stoimenov; Valentina N Nikolic
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

Review 7.  Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.

Authors:  Ioan Tilea; Andreea Varga; Razvan Constantin Serban
Journal:  Diagnostics (Basel)       Date:  2021-05-15

8.  Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.

Authors:  Jochen Wöhrle; Mahir Karakas; Ulrike Trepte; Julia Seeger; Birgid Gonska; Wolfgang Koenig; Wolfgang Rottbauer
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

9.  Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.

Authors:  Simona Hogas; Stefana C Bilha; Dumitru Branisteanu; Mihai Hogas; Abduzhappar Gaipov; Mehmet Kanbay; Adrian Covic
Journal:  Arch Med Sci       Date:  2016-03-22       Impact factor: 3.318

10.  Ticagrelor attenuates myocardial ischaemia-reperfusion injury possibly through downregulating galectin-3 expression in the infarct area of rats.

Authors:  Xiaogang Liu; Ye Gu; Yufeng Liu; Mingjing Zhang; Yuting Wang; Liqun Hu
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.